MALIGNANT JOINT NEOPLASM

This adverse event was reported 16 times

MALIGNANT JOINT NEOPLASM is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 LINAGLIPTIN AND METFORMIN HYDROCHLORIDE 1 0.0008
1 TESAMORELIN 1 0.0006
2 METHOCARBAMOL TABLETS 1 0.0001
3 METHOCARBAMOL 1 0.0000
4 CABOZANTINIB 2 0.0000
5 UPADACITINIB 2 0.0000
6 PACLITAXEL 2 0.0000
7 LATANOPROST 1 0.0000
8 CARBOPLATIN 2 0.0000
9 LEUPROLIDE ACETATE 1 0.0000
See all drugs enriched for association with MALIGNANT JOINT NEOPLASM